ロード中...
The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis
INTRODUCTION: Treatment-related quality of life (QOL) is an important aspect of diabetes management. Here, we investigated the influence of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on treatment-related QOL in patients with type 2 diabetes mellitus treated with insulin. METHODS: This was a pr...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5446390/ https://ncbi.nlm.nih.gov/pubmed/28516377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0267-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|